04/06/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 4/6/2020. This five-page document, updated on April 6, 2020, provides advice on the use of masks in communities, during home care, and in healthcare settings in areas that have reported cases of COVID-19. It is intended for individuals in the community, public health and infection prevention and control (IPC) professionals, health care managers, health care workers (HCWs), and community health workers. This updated version includes a section on advice to decision-makers on the use of masks for healthy people in community settings. (PDF)
04/06/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 4/6/2020. This seven-page document, updated on April 6, 2020, summarizes World Health Organization recommendations for the rational use of personal protective equipment (PPE) for novel coronavirus (COVID-19), in health care and community settings, including the handling of cargo. It also assesses the current disruption of the global supply chain and considerations for decision-making during severe shortages of PPE. (PDF)
04/06/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 4/6/2020. This guidance is provided to assist healthcare facilities in mitigating healthcare personnel staffing shortages that might occur because of COVID-19, and details contingency capacity strategies to mitigate staffing shortages. (Text)
04/06/2020 12:00 AM EDT
Source: National Emerging Special Pathogens Training and Education Center (NETEC). Published: 4/6/2020. This webinar provides tips on teaching resiliency among healthcare workers, risk factors, how to overcome and develop a peer support plan, a resiliency road map, and overall strategies for the COVID-19 pandemic. It discusses challenges for healthcare workers in a pandemic, and risk factors for psychological distress. (Video or Multimedia)
04/06/2020 12:00 AM EDT
Source: International Federation of Red Cross and Red Crescent Societies (IFRC). Published: 4/6/2020. To effectively care for and support volunteers involved in a COVID-19 response and to ensure that high quality mental health and psychosocial support is being provided to the community, National Societies must establish a robust volunteer care system, one that includes supportive supervision, to enhance their safety and psychosocial well-being. This seven-page guidance note provides a quick reference for National Societies to establish and support supervisors in provision of supportive supervision to volunteers during COVID-19. (PDF)
Discontinuation of Isolation for Persons with COVID-19 Not in Healthcare Settings (Interim Guidance)
04/04/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 4/4/2020. This guidance, updated on April 4, 2020, is for healthcare providers and public health officials managing patients with coronavirus disease (COVID-19) under home isolation. It should be used to help prevent the spread of COVID-19 in the community, and is a reference to guide healthcare staff and public health officials before discontinuing home isolation of patients with COVID-19. (Text)
04/04/2020 12:00 AM EDT
Source: National Institute for Occupational Safety and Health [Centers for Disease Control and Prevention] (CDC NIOSH). Published: 4/4/2020. The National Personal Protective Technology Laboratory (NPPTL) is conducting a series of respirator assessments in response to the COVID-19 pandemic. This nine-page protocol establishes a method for assessing the particulate filter efficiency and change in static fit of N95 respirators following decontamination protocols. (PDF)
04/03/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/3/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the ARIES® SARS-CoV-2 Assay, which received an Emergency Use Authorization from the Food and Drug Administration on April 3, 2020. The ARIES® SARS-CoV-2 Assay is authorized for use on respiratory specimens from individuals suspected of COVID-19 by their healthcare provider. (PDF)
04/03/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/3/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the ScienCell™ SARS-CoV-2 Coronavirus Real-time RT-PCR (RT-qPCR) Detection Kit, which received an Emergency Use Authorization from the Food and Drug Administration on April 3, 2020. The ScienCell™ SARS-CoV-2 Coronavirus Real-time RT-PCR (RT-qPCR) Detection Kit is authorized for use on using respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
04/03/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/3/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Logix Smart Coronavirus Disease 2019 (COVID-19) kit, which received an Emergency Use Authorization from the Food and Drug Administration on April 3, 2020. The Logix Smart COVID-19 kit is authorized for use on using respiratory specimens collected from individuals who are suspected of COVID-19 by their healthcare provider. (PDF)
04/03/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/3/2020. This one-page document authorizes the emergency use of the MGH (Massachusetts General Hospital) COVID-19 SARS-CoV-2 RT-PCR Assay, which is eligible for authorization under the March 31, 2020, Emergency Use Authorization (EUA) for Molecular-based Laboratory Developed Tests for Detection of Nucleic Acid from SARS-CoV-2 (Molecular LDT COVID-19 Authorized Test). (PDF)
04/03/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/3/2020. This eight-page letter describes how the Food and Drug Administration concluded that based on the totality of scientific evidence available that certain product classifications for imported disposable filtering facepiece respirators (FFRs or respirators) that are manufactured in China and not National Institute for Occupational Safety and Health (NIOSH)-approved and for which data exist that support the respirators’ authenticity, are appropriate to protect the public health or safety during the COVID-19 pandemic. (PDF)
04/03/2020 12:00 AM EDT
Source: Occupational Safety and Health Administration [U.S. Department of Labor] (OSHA). Published: 4/3/2020. This memorandum provides interim guidance to Compliance Safety and Health Officers for enforcing the Respiratory Protection standard and certain other health standards, with regard to supply shortages of disposable N95 filtering facepiece respirators (FFRs). This guidance applies in all industries, including workplaces in which healthcare personnel are exposed to patients with suspected or confirmed coronavirus disease 2019 (COVID-19) and other sources of SARS-CoV-2 (the virus that causes COVID-19). (Text)
04/02/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/2/2020. This 15-page guidance, updated on April 2, 2020, provides a policy to help expand the availability of general use face masks for the general public and particulate filtering facepiece respirators (including N95 respirators) for healthcare professionals during the COVID-19 pandemic. (PDF)
04/02/2020 12:00 AM EDT
Source: Government of Canada. Published: 4/2/2020. This guidance provides clinicians with interim advice on timely, effective, and safe supportive management of adult and pediatric patients with suspected or confirmed COVID-19. It is not meant to replace clinical judgment or specialist consultation, but rather to strengthen the clinical management of these patients. Best practices for triage and optimized supportive care are included. (Text)
03/31/2020 12:00 AM EDT
Source: National Institute for Occupational Safety and Health [Centers for Disease Control and Prevention] (CDC NIOSH). Published: 3/31/2020. The National Personal Protective Technology Laboratory (NPPTL) is conducting a series of respirator assessments in response to the COVID-19 pandemic. This 10-page protocol establishes a method for assessing the particulate filter efficiency of respirators approved under standards used in other countries that are similar to NIOSH-approved N95 respirators. (PDF)
03/30/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 3/30/2020. This web page provides a simple screening tool that can be used to identify people with symptoms that indicate they might have a respiratory infection. Although not every person who has respiratory infection symptoms will have coronavirus disease 2019 (COVID-19), using this tool during community spread of COVID-19 may help separate those who are more likely to have COVID-19 from the general population at entry to a homeless shelter or other homeless service program. (Text)
03/30/2020 12:00 AM EDT
Source: National Institute for Occupational Safety and Health [Centers for Disease Control and Prevention] (CDC NIOSH). Published: 3/30/2020. The National Personal Protective Technology Laboratory (NPPTL) is conducting a series of respirator assessments in response to the COVID-19 pandemic. This nine-page protocol establishes a method for assessing the particulate filter efficiency of N95 respirators that are stored in stockpiles and are beyond their designated shelf life. (PDF)
03/27/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 3/27/2020. This web page provides guidance on the identification or screening of healthcare workers and inpatients with suspected COVID-19 in non-U.S. healthcare settings. Rationale, requirements, and considerations are discussed for three broad case identification strategies: passive, enhanced passive, and active. (Text)
03/10/2020 12:00 AM EDT
Source: American Health Lawyers Association (AHLA). Published: 3/10/2020. This 17-page resource, updated on March 10, 2020, is a toolkit for hospitals and others to respond to the coronavirus (COVID-19) based on the legal and accreditation requirements and recommendations that should guide hospital decisions and preparedness activities. It outlines eight steps for hospitals to take to protect their patients, employees, and communities, starting with continuing to assess preparedness. (PDF)
03/01/2020 12:00 AM EST
Source: Fenway Institute. Published: 3/2020. This 18-page document provides information about COVID-19; specific information about particular concerns for LGBTQIA+ people, and people living with HIV; and guidance to avoid being infected. (PDF)
No hay comentarios:
Publicar un comentario